ARCHIVES

Parkinson Heads Oncology At Amgen

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

No Controversy Over Cancer Act This Time

May 25, 1990

Clinical Trials Approved By NCI

March 26, 2004